The recent study in Menopause is a critical reminder that sexual problems are as prevalent in women aged 65 and older as they are in midlife women, despite being understudied. FemmePharma views this as more than a data point—it highlights a systemic failure rooted in ageism that often overlooks the vitality of older women. The lack of reported distress among older women may reflect a lack of awareness of effective treatments or a discomfort in discussing the issue, rather than a lack of concern. Healthcare systems must mandate standardized screening and normalize discussions of sexual function and wellness across a woman's entire lifespan, not just their reproductive years. -Gerianne DiPiano, CEO and Founder, FemmePharma